학술논문
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia
Document Type
Artikel
Author
Source
Molecular therapy : the journal of the American Society of Gene Therapy. 29(12):3410-3421
Subject
Language
English
English
English
ISSN
1525-0024